Scott Wilkinson

Also affiliated with National Cancer Institute

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 38 papers. Top paper: “Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response”.

Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2344

N/A

1.2DataRank · unranked

38 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Defining cellular population dynamics at single-cell resolution during prostate cancer progression

eLife(2022)10.7554/elife.79076

N/A

1.1DataRank · unranked

29 citations

Sonali Arora, Ye Zheng, Erica T. Goddard, Ilsa M. Coleman, Anson T. Ku +17 more

Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates

Nature Communications(2024)10.1038/s41467-024-53034-6

N/A

0.493DataRank · unranked

15 citations

Meghana S. Pagadala, Maria A. Cardenas, Roshan S. Prabhu, Subir Goyal, Chengjing Zhou +34 more

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

Discover Oncology(2022)10.1007/s12672-022-00565-3

N/A

0.330DataRank · unranked

8 citations

Margaret White, Brian J. Capaldo, Anson T. Ku, Supreet Agarwal, Lei Fang +10 more

Localized high-risk prostate cancer harbors an androgen receptor activity–low subpopulation susceptible to HER2 inhibition

Journal of Clinical Investigation(2025)10.1172/jci189900

N/A

0.172DataRank · unranked

2 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +26 more

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00185-w

N/A

0DataRank · unranked

241 citations

Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu +32 more

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

European Urology(2021)10.1016/j.eururo.2021.03.009

N/A

0DataRank · unranked

74 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0121

N/A

0DataRank · unranked

48 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

medRxiv(2021)10.1101/2021.01.27.21250464

N/A

0DataRank · unranked

4 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Comparison of Approaches to Transcriptomic Analysis in Multi-Sampled Tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.11.443668

N/A

0DataRank · unranked

2 citations

Scott Wilkinson, Adam G. Sowalsky, Anson T. Ku

Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi’s Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate

European Urology(2021)10.1016/j.eururo.2021.06.002

N/A

0DataRank · unranked

1 citations

Huihui Ye, Rosina T. Lis, Adam G. Sowalsky, Scott Wilkinson

Prostate-specific membrane antigen is a biomarker for residual disease following neoadjuvant intense androgen deprivation therapy in prostate cancer

medRxiv(2021)10.1101/2021.10.28.21265614

N/A

0DataRank · unranked

0 citations

Rosina T. Lis, Anson T. Ku, Nicholas T. Terrigino, Shana Y. Trostel, Nicole V. Carrabba +5 more

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0851

N/A

0DataRank · unranked

32 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Modeling Androgen Deprivation Therapy–Induced Prostate Cancer Dormancy and Its Clinical Implications

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-1037

N/A

0DataRank · unranked

25 citations

Hui Xue, Fan Mo, Yen-yi Lin, Dong Lin, Nelson K.Y. Wong +16 more

Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer

The Journal of Urology(2022)10.1097/ju.0000000000002492

N/A

0DataRank · unranked

5 citations

Rosina T. Lis, Anson T. Ku, Nicholas T. Terrigino, Nichelle C. Whitlock, Shana Y. Trostel +6 more

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.07.495219

N/A

0DataRank · unranked

9 citations

Gal Dinstag, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis, Katherine Caley +25 more

A case report of multiple primary prostate tumors with differential drug sensitivity

Nature Communications(2020)10.1038/s41467-020-14657-7

N/A

0DataRank · unranked

40 citations

Stephanie A. Harmon, Nicholas T. Terrigino, Fatima Karzai, Peter A. Pinto, Ravi A. Madan +16 more

Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer

medRxiv(2022)10.1101/2022.03.10.22271799

N/A

0DataRank · unranked

2 citations

Ines Figueiredo, Rosina T. Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan +26 more

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

medRxiv(2022)10.1101/2022.06.04.22276001

N/A

0DataRank · unranked

1 citations

Margaret White, Brian J. Capaldo, Anson T. Ku, Supreet Agarwal, Lei Fang +10 more

Comment on: Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis by Jing Li et al.

Translational Oncology(2022)10.1016/j.tranon.2022.101347

N/A

0DataRank · unranked

0 citations

Adam G. Sowalsky, Scott Wilkinson

1033 Stem-like CD8 T-cells residing in antigen presenting immune niches are prognostic for local control in brain metastases and are sustained following radiation therapy

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1033

N/A

0DataRank · unranked

0 citations

Prasanthi Chappa, Nataliya Prokhnevska, Maria F. Cardenas, Roshan S. Prabhu, Jim Zhong +20 more

Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad192

N/A

0DataRank · unranked

1 citations

Adam G. Sowalsky, Scott Wilkinson

Prediction of cancer treatment response from histopathology images through imputed transcriptomics

Research Square(2023)10.21203/rs.3.rs-3193270/v1

N/A

0DataRank · unranked

6 citations

Danh-Tai Hoang, Gal Dinstag, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis +25 more

Data from A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

(2023)10.1158/1078-0432.c.6530387

N/A

0DataRank · unranked

0 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Data from A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

(2023)10.1158/1078-0432.c.6530387.v1

N/A

0DataRank · unranked

0 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response

(2023)10.1158/1078-0432.c.6530054.v1

N/A

0DataRank · unranked

0 citations

Stephanie M. Walker, Scott Wilkinson, Ravi A. Madan, Joanna H. Shih, Maria J. Merino +20 more

Data from Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer

(2023)10.1158/1078-0432.c.6532445

N/A

0DataRank · unranked

0 citations

Ines Figueiredo, Rosina T. Lis, Ilsa M. Coleman, Bora Gurel, Denisa Bogdan +26 more

A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics

Nature Cancer(2024)10.1038/s43018-024-00793-2

N/A

0DataRank · unranked

141 citations

Gal Dinstag, Eldad D. Shulman, Leandro C. Hermida, Doreen S. Ben-Zvi, Efrat Elis +26 more

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0559

N/A

0DataRank · unranked

46 citations

Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg +35 more

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition

medRxiv(2024)10.1101/2024.02.09.24302395

N/A

0DataRank · unranked

4 citations

Anson T. Ku, Rosina T. Lis, I. King, Daniel Low, Shana Y. Trostel +21 more

77P Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

ESMO Open(2024)10.1016/j.esmoop.2024.103818

N/A

0DataRank · unranked

0 citations

D. Westaby, Ines Figueiredo, A. De Haven Brandon, Ana Padilha, W. Yuan +15 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5

N/A

0DataRank · unranked

6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more

Defining cellular population dynamics at single cell resolution during prostate cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.02.482711

N/A

0DataRank · unranked

2 citations

Sonali Arora, Ye Zheng, Erica T. Goddard, Ilsa M. Coleman, Anson T. Ku +13 more

MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity

Oncogene(2020)10.1038/s41388-020-01389-7

N/A

0DataRank · unranked

34 citations

Shana Y. Trostel, Scott Wilkinson, Nicholas T. Terrigino, S. Thomas Hennigan, Ross Lake +8 more

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

medRxiv(2020)10.1101/2020.09.29.20199711

N/A

0DataRank · unranked

12 citations

Huihui Ye, Fatima Karzai, Stephanie A. Harmon, Nicholas T. Terrigino, David James VanderWeele +23 more

A tale of lineage plasticity: Intense neoadjuvant testosterone lowering therapy in localized prostate cancer (PCa) harboring high-risk genomic signatures.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.368

N/A

0DataRank · unranked

0 citations

Ravi A. Madan, Adam G. Sowalsky, Marijo Bilušić, Guinevere Chun, Lisa M. Cordes +9 more

Multiple primary prostate tumors with differential drug sensitivity.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.342

N/A

0DataRank · unranked

0 citations

Huihui Ye, Nicholas T. Terrigino, Nicole V. Carrabba, Rayann Atway, Shana Y. Trostel +14 more